TGTX logo

TG Therapeutics (TGTX) Accounts receivable

Annual accounts receivable:

$129.19M+$78.09M(+152.84%)
December 31, 2024

Summary

  • As of today (June 2, 2025), TGTX annual accounts receivable is $129.19 million, with the most recent change of +$78.09 million (+152.84%) on December 31, 2024.
  • During the last 3 years, TGTX annual accounts receivable has risen by +$127.80 million (+9200.58%).
  • TGTX annual accounts receivable is now at all-time high.

Performance

TGTX Accounts receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTGTXbalance sheet metrics

Quarterly accounts receivable:

$190.12M+$60.94M(+47.17%)
March 1, 2025

Summary

  • As of today (June 2, 2025), TGTX quarterly accounts receivable is $190.12 million, with the most recent change of +$60.94 million (+47.17%) on March 1, 2025.
  • Over the past year, TGTX quarterly accounts receivable has increased by +$125.14 million (+192.57%).
  • TGTX quarterly accounts receivable is now at all-time high.

Performance

TGTX Quarterly accounts receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTGTXbalance sheet metrics

Accounts receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

TGTX Accounts receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+152.8%+192.6%
3 y3 years+9200.6%+10000.0%
5 y5 years--

TGTX Accounts receivable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high>+9999.0%at high>+9999.0%
5 y5-yearat high>+9999.0%at high>+9999.0%
alltimeall timeat high>+9999.0%at high>+9999.0%

TGTX Accounts receivable History

DateAnnualQuarterly
Mar 2025
-
$190.12M(+47.2%)
Dec 2024
$129.19M(+152.8%)
$129.19M(+11.6%)
Sep 2024
-
$115.73M(+38.4%)
Jun 2024
-
$83.61M(+28.7%)
Mar 2024
-
$64.98M(+27.2%)
Dec 2023
$51.09M(>+9900.0%)
$51.09M(+29.9%)
Sep 2023
-
$39.32M(+124.9%)
Jun 2023
-
$17.48M(+102.8%)
Mar 2023
-
$8.62M(>+9900.0%)
Dec 2022
$0.00
$0.00(0.0%)
DateAnnualQuarterly
Sep 2022
-
$0.00(-100.0%)
Jun 2022
-
$88.00K(-90.3%)
Mar 2022
-
$903.00K(-35.0%)
Dec 2021
$1.39M(>+9900.0%)
$1.39M(+0.4%)
Sep 2021
-
$1.38M(+48.7%)
Jun 2021
-
$931.00K(+20.8%)
Mar 2021
-
$771.00K(>+9900.0%)
Dec 2020
$0.00(-100.0%)
$0.00(-100.0%)
Jun 2002
-
$501.70K(+159.9%)
Dec 2000
$193.00K(-35.7%)
$193.00K(-35.7%)
Dec 1999
$300.00K
$300.00K

FAQ

  • What is TG Therapeutics annual accounts receivable?
  • What is the all time high annual accounts receivable for TG Therapeutics?
  • What is TG Therapeutics annual accounts receivable year-on-year change?
  • What is TG Therapeutics quarterly accounts receivable?
  • What is the all time high quarterly accounts receivable for TG Therapeutics?
  • What is TG Therapeutics quarterly accounts receivable year-on-year change?

What is TG Therapeutics annual accounts receivable?

The current annual accounts receivable of TGTX is $129.19M

What is the all time high annual accounts receivable for TG Therapeutics?

TG Therapeutics all-time high annual accounts receivable is $129.19M

What is TG Therapeutics annual accounts receivable year-on-year change?

Over the past year, TGTX annual accounts receivable has changed by +$78.09M (+152.84%)

What is TG Therapeutics quarterly accounts receivable?

The current quarterly accounts receivable of TGTX is $190.12M

What is the all time high quarterly accounts receivable for TG Therapeutics?

TG Therapeutics all-time high quarterly accounts receivable is $190.12M

What is TG Therapeutics quarterly accounts receivable year-on-year change?

Over the past year, TGTX quarterly accounts receivable has changed by +$125.14M (+192.57%)
On this page